Dr. Pelargos Panayiotis earned his graduate degree from the Institute for Clinical & Translational Science at the University of California, Irvine and his medical degree from the University of California, Irvine School of Medicine. During medical school, he spent two years in the Yang Lab conducting clinical and translational research. Some of this research projects included investigating the role of EMP2 in glioblastoma development, the effectiveness of CCL21-coupled vault nanoparticles in treating glioblastoma in mouse models, and the effectiveness of LITT in treating various metastatic and primary tumors. His hobbies includes sports, especially basketball and soccer, and reading. Currently, Dr. Panayiotis is a neurosurgery resident at the University of Oklahoma and is interested in skull base surgery and neuro-oncology. He will be completing a fellowship in skull base surgery and advanced surgical neuro-oncology at Washington University in St. Louis upon graduation and then going on to a career in academic neurosurgery.